Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharynx Cancer and Quality of Life —Reply

In Reply In reaction to our recent report on quality-of-life outcomes following neoadjuvant chemotherapy and transoral robotic surgery (NECTORS) for human papillomavirus virus –associated oropharyngeal squamous cell carcinoma (HPV-OPSCC), Granell and Gutierrez-Fonseca have raised concerns to which we would like to respond.
Source: JAMA Otolaryngology - Head and Neck Surgery - Category: ENT & OMF Source Type: research